Cinven
NICE recommends STADA and Calliditas’ Kinpeygo to treat rare kidney disease IgAN
Affecting approximately 14,000 in England, IgA nephropathy occurs when IgA accumulates in the kidneys, causing inflammation and scarring
International survey reveals varying effects of oral medicines for Parkinson’s
More than 65% of respondents reported variations in the effects of taking oral medications
Takeda divests over-the-counter and prescription drugs to Stada for $660m
Japanese pharma said it has plans to divest $10bn in non-core assests
Trouble at the top of Stada as Bain and Cinven mull fresh bid
Private equity firms request a waiver from the 12-month stay on subsequent bids
No deal for Stada as private equity takeover bid collapses
65.52% of investors supported the takeover, just shy of the 67.5% needed to close the deal
Private equity firms agree deal to take over Stada
Cinven and Bain Capital beat out competition from Advent International
Stada opens books to let formal bidding commence
Cinven, Advent International and Bain Capital now have opportunity to revise their bids
Advent tops Cinven offer for Stada as third suitor looms
Values the OTC and generics specialist at €3.6bn, with offer open until 27 February
Stada confirms Cinven as one of two takeover bidders
Private equity group offers €3.6bn for the generics and over-the-counter medicines manufacturer
Stada CEO departs ahead of proxy battle with activist investors
Hartmut Retzlaff cites health reasons amid rumours of a company sale